Results 81 to 90 of about 241,150 (203)

p21-activated kinase-1 promotes aggressive phenotype, cell proliferation, and invasion in gestational trophoblastic disease

, 2010
Gestational trophoblastic disease (GTD) includes hydatidiform mole (HM), which can develop persistent gestational trophoblastic neoplasia requiring chemotherapy; choriocarcinoma, which is a frankly malignant tumor; placental site trophoblastic tumor; and
Chan, DCW, Kong, DSH, Ho, JWK, Yeung, MCW, Ngan, HYS, Siu, MKY, Cheung, ANY, Zhang, H   +7 more
core   +1 more source

Laboratory findings of patients with complete hydatidiform mole associated with spontaneous remission or progression to gestational trophoblastic neoplasia.

, 2022
Laboratory findings of patients with complete hydatidiform mole associated with spontaneous remission or progression to gestational trophoblastic neoplasia.
Joffre Amim Junior (14203632), Neil S. Horowitz (4857427), Antonio Braga (1275765), Luana Giongo Pedrotti (12660685), Kevin M. Elias (12438348), Ross S. Berkowitz (13926037), Ana Clara Canelas (14203620), Izildinha Maesta (14203626), Marina Bessel (4344892), Ana Paula Vieira dos Santos Esteves (14203629), Jorge Rezende Filho (14203635), Berenice Torres (14203623)   +11 more
core   +1 more source

Toward risk‐stratified management of placental site nodules with atypical features

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 8, Page 1640-1640, August 2026.
Tingting Xu, Shuhong Li
wiley   +1 more source

Gestational Trophoblastic Disease: Diagnostic and Therapeutic Updates in Light of Recent Evidence: A Literature Review

Medicina
Background/objectives: Gestational trophoblastic diseases (GTDs) are rare premalignant and malignant conditions characterized by abnormal proliferation of trophoblastic tissue. They are often asymptomatic but may present with vaginal bleeding.
Giuseppe Gullo, Marinì Satullo, Eleonora Conti, Silvia Ganduscio, Elena Chitoran, Zoltan Kozinszky, Karolina Kowalcze, Robert Krysiak, Valentina Billone, Gaspare Cucinella   +9 more
doaj   +1 more source

Clinical characteristics of patients with complete hydatidiform mole associated with spontaneous remission or progression to gestational trophoblastic neoplasia.

, 2022
Clinical characteristics of patients with complete hydatidiform mole associated with spontaneous remission or progression to gestational trophoblastic neoplasia.
Joffre Amim Junior (14203632), Neil S. Horowitz (4857427), Antonio Braga (1275765), Luana Giongo Pedrotti (12660685), Kevin M. Elias (12438348), Ross S. Berkowitz (13926037), Ana Clara Canelas (14203620), Izildinha Maesta (14203626), Marina Bessel (4344892), Ana Paula Vieira dos Santos Esteves (14203629), Jorge Rezende Filho (14203635), Berenice Torres (14203623)   +11 more
core   +1 more source

Abstracts

Molecular Oncology, Volume 20, Issue S1, Page 1-692, August 2026.
Abstracts submitted to the ‘EACR 2026 Congress: Innovative Cancer Science’, from 08–11 June 2026 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley   +1 more source

Radiographically occult pulmonary metastases from gestational trophoblastic neoplasia

, 2017
Gestational trophoblastic neoplasia (GTN) is a spectrum of diseases including partial and complete hydatidiform moles, placental site trophoblastic tumor, and choriocarcinoma.
Maria del Pilar Aguinaga, PhD, Edward Hills, MD, Tina Hong, MD   +2 more
core   +1 more source

Low-risk gestational trophoblastic neoplasia outcome after treatment with VMP regimen from 2005 to 2017

Taiwanese Journal of Obstetrics & Gynecology, 2019
Objective: To evaluate the efficacy and toxicity of VMP regimen applied to the patients with low-risk gestational trophoblastic neoplasia (LR-GTN) treated in Anhui provincial hospital.
Chen-Chen Zhu, Han-Yuan Liu, Ying Wei, Zhen Shen, Li-Li Qian, Wei-Guo Song, Juan Wang, Da-Bao Wu, Xue-Fen Zhang, Ying Zhou   +9 more
doaj   +1 more source

Methotrexate, bleomycin, and etoposide in the treatment of gestational trophoblastic neoplasia

, 2005
OBJECTIVE: The combination of methotrexate (1 g/m 2 day 1), bleomycin (10 mg day 3), and etoposide (100 mg/m 2 days 1-5) (MBE) has been used for disease relapse or as a second-line chemotherapy in the treatment of gestational trophoblastic neoplasia (GTN)
Ka-Wai Lam, Chan, KKL, Ngan, HYS, Hextan Y. S. Ngan, Tam, KF, Kar-Fai Tam, Lam, KW, Karen K. L. Chan   +7 more
core   +1 more source

Gestational trophoblastic neoplasia in the 1990s.

The Yale journal of biology and medicine, 1992
Version of ...
openaire   +2 more sources